Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy

BACKGROUND: The safety and immunogenicity of a personalized neoantigen-based peptide vaccine, iNeo-Vac-P01, was reported previously in patients with a variety of cancer types. The current study investigated the synergistic effects of radiofrequency ablation (RFA) and neoantigen vaccination in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Shou, Jiawei, Mo, Fan, Zhang, Shanshan, Lu, Lantian, Han, Ning, Liu, Liang, Qiu, Min, Li, Hongseng, Han, Weidong, Ma, Dongying, Guo, Xiaojie, Guo, Qianpeng, Huang, Qinxue, Zhang, Xiaomeng, Ye, Shengli, Pan, Hongming, Chen, Shuqing, Fang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559398/
https://www.ncbi.nlm.nih.gov/pubmed/36248865
http://dx.doi.org/10.3389/fimmu.2022.1000681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559398/
https://www.ncbi.nlm.nih.gov/pubmed/36248865
http://dx.doi.org/10.3389/fimmu.2022.1000681

Ejemplares similares